Leinco Technologies, La Jolla Institute for Immunology to Develop Novel Covid-19 Diagnostic Tools
Leinco will gain exclusive access to certain SARS-CoV-2 antibodies directed against the virus’ N protein and make the antibodies commercially available.
Read More